UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection

Therapeutic Advances in Infectious Disease, 2021-01, Vol.8

2021

Volltextzugriff (PDF)

Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR)

BMC infectious diseases, 2020-10, Vol.20 (1), p.1-783, Article 783

2020

Volltextzugriff (PDF)

Regulation, risk and safety of Faecal Microbiota Transplant

Infection prevention in practice, 2020-09, Vol.2 (3), p.100069-100069, Article 100069

2020

Volltextzugriff (PDF)

Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3556-3561

2016

Volltextzugriff (PDF)

The Enigma ML FluAB-RSV assay: a fully automated molecular test for the rapid detection of influenza A, B and respiratory syncytial viruses in respiratory specimens

Expert review of molecular diagnostics, 2015-01, Vol.15 (1), p.23-32

2015

Volltextzugriff (PDF)

Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)

Infectious disease reports, 2023-05, Vol.15 (3), p.238-254

2023

Volltextzugriff (PDF)

A solution to the problem of antibiotic induced collateral damage to the gut microbiome

The Lancet infectious diseases, 2019-05, Vol.19 (5), p.451-452

Goldenberg, Simon D

2019

Volltextzugriff (PDF)

Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial

BMJ open, 2020-05, Vol.10 (5), p.e038847

2020

Volltextzugriff (PDF)

Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes

Journal of antimicrobial chemotherapy, 2018-10, Vol.73 (10), p.2851-2855

2018

Volltextzugriff (PDF)

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report

Infectious disease reports, 2022-01, Vol.14 (1), p.56-62

2022

Volltextzugriff (PDF)

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

The Lancet infectious diseases, 2018-03, Vol.18 (3), p.296-307

2018

Volltextzugriff (PDF)

Expanding the armamentarium for the treatment of Clostridium difficile infection

The Lancet infectious diseases, 2017-07, Vol.17 (7), p.678-680

Goldenberg, Simon D

2017

Volltextzugriff (PDF)

A cost benefit analysis of the Luminex xTAG Gastrointestinal Pathogen Panel for detection of infectious gastroenteritis in hospitalised patients

The Journal of infection, 2015-05, Vol.70 (5), p.504-511

2015

Volltextzugriff (PDF)

Meeting the Challenge of Antimicrobial Resistance in Cirrhosis: The Invisible Threat That Lies Within

Gastroenterology (New York, N.Y. 1943), 2021-08, Vol.161 (2), p.413-415

2021

Volltextzugriff (PDF)

Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer: A reply

The Journal of infection, 2018-04, Vol.76 (4), p.424-426

2018

Volltextzugriff (PDF)

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2529-2539

2018

Volltextzugriff (PDF)

Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection

The lancet. Gastroenterology & hepatology, 2023-02, Vol.8 (2), p.109-110

2023

Volltextzugriff (PDF)

Hidden burden of undiagnosed Clostridium difficile infection

The Lancet infectious diseases, 2014-12, Vol.14 (12), p.1167-1168

Goldenberg, Simon D

2014

Volltextzugriff (PDF)

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020

Clinical immunology (Orlando, Fla.), 2020-09, Vol.218, p.108542-108542

2020

Volltextzugriff (PDF)

Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards

Journal of controlled release, 2022-10, Vol.350, p.324-331

2022

Volltextzugriff (PDF)

A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

United European gastroenterology journal, 2021-03, Vol.9 (2), p.229-247

2021

Volltextzugriff (PDF)

Laboratory diagnosis of Clostridium difficile

The Lancet infectious diseases, 2013-11, Vol.13 (11), p.909-911

Goldenberg, Simon D

2013

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(94)
Bücher
(2)

Sprache

Englisch
(94)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection

Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR)

Evidence for Community Transmission of Community-Associated but Not Health-Care-Associated Methicillin-Resistant Staphylococcus Aureus Strains Linked to Social and Material Deprivation: Spatial Analysis of Cross-sectional Data

Regulation, risk and safety of Faecal Microbiota Transplant

Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting

The Enigma ML FluAB-RSV assay: a fully automated molecular test for the rapid detection of influenza A, B and respiratory syncytial viruses in respiratory specimens

Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)

A solution to the problem of antibiotic induced collateral damage to the gut microbiome

Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial

Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Expanding the armamentarium for the treatment of Clostridium difficile infection

A cost benefit analysis of the Luminex xTAG Gastrointestinal Pathogen Panel for detection of infectious gastroenteritis in hospitalised patients

Meeting the Challenge of Antimicrobial Resistance in Cirrhosis: The Invisible Threat That Lies Within

Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer: A reply

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness

Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection

Hidden burden of undiagnosed Clostridium difficile infection

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020

Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards

A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

Laboratory diagnosis of Clostridium difficile

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Suchergebnisse filtern